FBXO28 promotes the malignancy of non-small cell lung cancer through ubiquitination-mediated activation of BRD4
Tumor immune dynamics and long-term clinical outcome of stage IIIA NSCLC patients treated with neoadjuvant chemoimmunotherapy
Myofibroblasts Derived Type V Collagen Promoting Tissue Mechanical Stress and Facilitating Metastasis and Therapy Resistance of Lung Adenocarcinoma Cells
Targeting ERBB3 and AKT to overcome adaptive resistance in EML4-ALK non-small cell lung cancer
The CLCF1-CNTFR axis drives an immunosuppressive tumor microenvironment and blockade enhances the effects of established cancer therapies
The PDE4DIP-AKAP9 axis promotes lung cancer growth through modulation of PKA signalling
CTDSPL2 promotes the progression of non-small lung cancer through PI3K/AKT signaling via JAK1
PRMT1 promotes Warburg effect by regulating the PKM2/PKM1 ratio in Non-small cell lung cancer
Family With Sequence Similarity 83, Member A (FAM83A) inhibits ferroptosis via wnt/β-catenin pathway in Lung Squamous Cell Cancer
Integrating clinico-pathological features and longitudinal liquid biopsy results to predict clinical benefit from immune checkpoint Inhibitors in advanced Non-Small Cell Lung Cancer patients